440 filings
Page 4 of 22
CORRESP
xs5qxfluanvdrft
21 Nov 22
Correspondence with SEC
12:00am
UPLOAD
2zvc1
21 Nov 22
Letter from SEC
12:00am
8-K
2jde3xf
14 Nov 22
AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
8xyynr50
25 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:52pm
8-K
icnps pzb7
23 Sep 22
Submission of Matters to a Vote of Security Holders
4:16pm
D
ymv0uk7cuudup7ogo o1
17 Aug 22
$629.96K in equity / options / securities to be acquired, sold $629.96K, 1 investor
2:15pm
DEFA14A
355g8v nv
12 Aug 22
Additional proxy soliciting materials
4:57pm
8-K
0dws caj8k
12 Aug 22
Material Modifications to Rights of Security Holders
4:09pm
8-K
u2de39w wear99
11 Aug 22
AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:08pm
8-K
q1zgg6bcvo1
4 Aug 22
Entry into a Material Definitive Agreement
9:15am
8-K
tairxoo6
28 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K/A
ebov7t5
26 Jul 22
Submission of Matters to a Vote of Security Holders
5:19pm
8-K/A
li9h4c7z
25 Jul 22
Submission of Matters to a Vote of Security Holders
4:05pm
DEFA14A
q4laj
18 Jul 22
Additional proxy soliciting materials
4:05pm
8-K
anc2qr4idb0
15 Jul 22
Submission of Matters to a Vote of Security Holders
5:07pm